&format=webp&quality=medium)
Hexagon Nutrition IPO: Hexagon Nutrition Ltd, a nutrition-focused healthcare company, is set to open its initial public offering (IPO) for subscription on June 5, 2026. The public issue will close on June 9, 2026, and is entirely an offer for sale (OFS) of 3.09 crore equity shares worth Rs 138.87 crore.
Since the issue is fully an OFS, all proceeds will go directly to the selling shareholders. According to the company's red herring prospectus (RHP) Arun Purushottam Kelkar, Subhash Purushottam Kelkar, Aditya Kelkar, and Nutan Subhash Kelkar, are the selling shareholders divesting part of their stake. The company itself will not receive any funds from the IPO.
Here are 5 key things that investors should know ahead of the June 5 launch:
The price band for the issue has been fixed at Rs 42 to Rs 45 per equity share. At the upper end, the company is valued at a pre-IPO market capitalisation of approximately Rs 553.13 crore.
For investors, the minimum application lot size is 333 shares, which translates to a minimum investment of Rs 14,985 for the retail category at the upper end of the price band.
The IPO subscription window will open on June 5, 2026, and close on June 9, 2026. The basis of allotment is expected to be finalised on June 10, with listing scheduled for June 12, 2026, on both the NSE and BSE. Ahead of the issue opening, the anchor investment is scheduled on June 4, 2026.
The Hexagon Nutrition IPO's allocation structure includes up to 50 per cent for Qualified Institutional Buyers (QIBs), at least 35 per cent for retail investors, and a minimum of 15 per cent for Non-Institutional Investors (NIIs).
Cumulative Capital Pvt Ltd and Catalyst Capital Partners Private Limited are acting as the book-running lead managers to the issue, while Kfin Technologies Ltd has been appointed as the registrar.
Founded in 1993, Hexagon Nutrition Ltd is a nutrition-focused company engaged in micronutrient premixes, clinical nutrition, therapeutic formulations, and ready-to-use foods. Its portfolio includes brands such as Pentasure, Obesigo, Pediagold, and Nutrone.
According to the information available in the company's website, the company operates manufacturing facilities in Nasik, Chennai, and Thoothukudi in India, along with an overseas unit in Uzbekistan. It also exports to more than 75 countries and maintains a distribution network across pharmacies, hospitals, e-commerce platforms, and online pharmacies.
With dedicated R&D centres in Nasik and Chennai, supported by a specialised team of professionals, the company continues to focus on nutrition innovation and global expansion.